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Background
There have been conflicting reports regarding the possi-
bility of an association between Lynch syndrome and
prostate cancer. Some reports indicate that individuals
with mismatch repair gene mutations may be at an
increased risk of prostate cancer, while others show little
to no evidence of an association. We are reporting a
family with multiple cancers including colorectal, endo-
metrial, ovarian, brain, skin and prostate.
Case report
The proband initially presented with a history colorectal
cancer at the age of 39. He also had a history of multiple
sebaceous adenomas and squamous cell carcinomas (ker-
atocanthoma type). Initial testing included germline
mutation analysis of the MH1, MSH2, and MSH6 genes
as tumor sample for MSI and IHC was not available.
Genetic test results revealed the IVS5+3A>T mutation in
MSH2. Based on the family history, including multiple
aggressive skin cancers, this mutation is consistent with a
diagnosis of Muir-Torre syndrome. As expected, the
MSH2 mutation tracks with colorectal, endometrial and
ovarian cancers in the family. Interestingly, the MSH2
mutation appears to be tracking with prostate cancer in
the family as well. Numerous men in this family have
been diagnosed with aggressive, early onset prostate can-
cer. The proband’s father, an obligate carrier of the
MSH2 mutation, was diagnosed with prostate cancer at
the age of 45 and passed away at the age of 49. A paternal
uncle was diagnosed with prostate cancer at the age of 41
and passed away of a brain tumor at the age of 60. He
passed away before having genetic testing so it is not
clear that he carried the familial MSH2 mutation;
however, the history of the brain tumor is suspicious.
Two additional uncles were diagnosed with prostate can-
cer at later ages (55 and 65). The uncle diagnosed at age
55 has a daughter that was diagnosed with endometrial
cancer in her 30s. The proband also reports three first
cousins with prostate cancer. One was diagnosed in his
40s and the other two in their 50s. One of the cousins
diagnosed with prostate cancer in his 50s was also diag-
nosed with colorectal cancer at the age of 42 and does
carry the familial MSH2 mutation.
Conclusion
In this family a mutation in the MSH2 mismatch repair
gene appears to be associated with an increased risk for
prostate cancer, indicating that additional research may
support the association between prostate cancer and
Lynch syndrome.
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